Dr. Weiss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany St Ste 2701
New Brunswick, NJ 08901Phone+1 732-235-2465Fax+1 732-235-8808
Summary
- Melanoma, immunotherapy, merkel cell carcinoma, cutaneous squamous cell carcinoma, basal cell carcinoma
Education & Training
- New York University School of MedicinePost-Doctoral Fellowship, 2015 - 2016
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2009 - 2012
- Albert Einstein College of MedicineClass of 2009
Certifications & Licensure
- NJ State Medical License 2021 - 2025
- CT State Medical License 2016 - 2022
- NY State Medical License 2011 - 2016
Clinical Trials
- A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma Start of enrollment: 2015 Nov 23
- A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC) Start of enrollment: 2020 Sep 14
Publications & Presentations
PubMed
- Patterns of brain metastases response to immunotherapy with pembrolizumab.Amit Mahajan, Sarah L Goldberg, Sarah A Weiss, Thuy Tran, Kanwar Singh
Journal of Neuro-Oncology. 2024-09-01 - 8 citationsA Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progres...Sarah A Weiss, Mario Sznol, Montaser Shaheen, Miguel-Ángel Berciano-Guerrero, Eva Muñoz Couselo
Clinical Cancer Research. 2024-01-05 - 1 citationsA bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better.Dijana Djureinovic, Sarah A Weiss, Irina Krykbaeva, Rihao Qu, Ioannis Vathiotis
Molecular Cancer. 2023-11-14
Press Mentions
- How Common Is Skin Cancer? And More Questions You’re Afraid to AskMay 2nd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: